Skip to main content

Table 4 The average brown florescence in each group (%) (n = 5)

From: Assessment of the hepatocyte protective effects of gypenoside and its phosphorylated derivative against DHAV-1 infection on duck embryonic hepatocytes

Group

Drug concentration (μg/mL)

Average brown florescence rate (%)

CC

0

11.70 ± 0.15d

VC

0

35.89 ± 1.07a

GPC

100

12.81 ± 0.25d

pGPC

25

12.42 ± 0.10d

GP

100

18.47 ± 0.21b

pGP

25

14.99 ± 0.43c

  1. Note: Data in the same column, marked with different letters indicates a significant difference (p < 0.05). CC group Cell control group, VC group Virus control group, GPC group Gypenoside control group, pGPC Phosphorylated gypenoside control group, E Gypenoside group, F Phosphorylated gypenoside group